Immunology and the menstrual cycle

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Oertelt Prigione, Sabine ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Arrhythmia; Autoimmune disease; Diabetes; Immune system; Lymphocytes; Menstrual cycle

Indexed keywords

CELL RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; IBUTILIDE; INSULIN; NEUROLEPTIC AGENT; PROGESTERONE; PROGESTERONE RECEPTOR;

ASTHMA; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BEHAVIOR; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL COUNT; DIABETES MELLITUS; HEART ARRHYTHMIA; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INSULIN TREATMENT; MENSTRUAL CYCLE; MONOCYTE; MULTIPLE SCLEROSIS; MUSCLE CONTRACTION; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TORSADE DES POINTES;

ARRHYTHMIAS, CARDIAC; ASTHMA; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DIABETES MELLITUS; ESTROGENS; FEMALE; HUMANS; MENSTRUAL CYCLE; PROGESTERONE; SCHIZOPHRENIA; SEX FACTORS; T-LYMPHOCYTES, REGULATORY;

EID: 84858437336     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.023     Document Type: Review

References (97)

1. Channing C.P., Schaerf F.W., Anderson L.D., Tsafriri A. Ovarian follicular and luteal physiology. Int Rev Physiol 1980, 22:117-201.
2. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
3. Miyaura H., Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002, 168:1087-1094.
4. Mortola J.F. Premenstrual syndrome-pathophysiologic considerations. N Engl J Med 1998, 338:256-257.
5. Cunningham M., Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 2011, 40:66-73.
6. Couse J.F., Lindzey J., Grandien K., Gustafsson J.A., Korach K.S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997, 138:4613-4621.
7. Hall J.M., McDonnell D.P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140:5566-5578.
8. Dosiou C., Hamilton A.E., Pang Y., Overgaard M.T., Tulac S., Dong J., et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 2008, 196:67-77.
9. Szekeres-Bartho J., Szekeres G., Debre P., Autran B., Chaouat G. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990, 125:273-283.
10. Tanriverdi F., Silveira L.F., MacColl G.S., Bouloux P.M. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003, 176:293-304.
11. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007, 87:905-931.
12. Scarpin K.M., Graham J.D., Mote P.A., Clarke C.L. Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal 2009, 7:e009.
13. Gameiro C.M., Romao F., Castelo-Branco C. Menopause and aging: changes in the immune system-a review. Maturitas 2010, 67:316-320.
14. Lee S., Kim J., Jang B., Hur S., Jung U., Kil K., et al. Fluctuation of peripheral blood T, B, and NK cells during a menstrual cycle of normal healthy women. J Immunol 2010, 185:756-762.
15. Lopez-Karpovitchs X., Larrea F., Cardenas R., Valencia X., Piedras J., Diaz-Sanchez V., et al. Peripheral blood lymphocyte subsets and serum immunoglobulins in Sheehan's syndrome and in normal women during the menstrual cycle. Rev Invest Clin 1993, 45:247-253.
16. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998, 161:3365-3374.
17. Faas M., Bouman A., Moesa H., Heineman M.J., de Leij L., Schuiling G. The immune response during the luteal phase of the ovarian cycle: a Th2-type response?. Fertil Steril 2000, 74:1008-1013.
18. Campbell D.J., Koch M.A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011, 11:119-130.
19. Heikkinen J., Mottonen M., Alanen A., Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004, 136:373-378.
20. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004, 112:38-43.
21. Prieto G.A., Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 2006, 118:58-65.
22. Arruvito L., Sanz M., Banham A.H., Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007, 178:2572-2578.
23. Peeva E., Venkatesh J., Diamond B. Tamoxifen blocks estrogen-induced B cell maturation but not survival. J Immunol 2005, 175:1415-1423.
24. Auerbach L., Hafner T., Huber J.C., Panzer S. Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle. Fertil Steril 2002, 78:83-89.
25. Franklin R.D., Kutteh W.H. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J Reprod Immunol 1999, 42:93-106.
26. Mathur S., Mathur R.S., Goust J.M., Williamson H.O., Fudenberg H.H. Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol. Clin Immunol Immunopathol 1979, 13:246-253.
27. Northern A.L., Rutter S.M., Peterson C.M. Cyclic changes in the concentrations of peripheral blood immune cells during the normal menstrual cycle. Proc Soc Exp Biol Med 1994, 207:81-88.
28. Brannstrom M., Friden B.E., Jasper M., Norman R.J. Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum. Eur J Obstet Gynecol Reprod Biol 1999, 83:213-217.
29. Polan M.L., Daniele A., Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril 1988, 49:964-968.
30. Angstwurm M.W., Gartner R., Ziegler-Heitbrock H.W. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997, 9:370-374.
31. Konecna L., Yan M.S., Miller L.E., Scholmerich J., Falk W., Straub R.H. Modulation of IL-6 production during the menstrual cycle in vivo and in vitro. Brain Behav Immun 2000, 14:49-61.
32. Bouman A., Moes H., Heineman M.J., de Leij L.F., Faas M.M. Cytokine production by natural killer lymphocytes in follicular and luteal phase of the ovarian cycle in humans. Am J Reprod Immunol 2001, 45:130-134.
33. Yovel G., Shakhar K., Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol 2001, 81:254-262.
34. Souza S.S., Castro F.A., Mendonca H.C., Palma P.V., Morais F.R., Ferriani R.A., et al. Influence of menstrual cycle on NK activity. J Reprod Immunol 2001, 50:151-159.
35. Sulke A.N., Jones D.B., Wood P.J. Variation in natural killer activity in peripheral blood during the menstrual cycle. Br Med J (Clin Res Ed) 1985, 290:884-886.
36. Case A.M., Reid R.L. Effects of the menstrual cycle on medical disorders. Arch Intern Med 1998, 158:1405-1412.
37. Steinberg A.D., Steinberg B.J. Lupus disease activity associated with menstrual cycle. J Rheumatol 1985, 12:816-817.
38. Colangelo K., Haig S., Bonner A., Zelenietz C., Pope J. Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 2011, 50:703-708.
39. Medeiros P.B., Febronio M.V., Bonfa E., Borba E.F., Takiuti A.D., Silva C.A. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 2009, 18:38-43.
40. Shabanova S.S., Ananieva L.P., Alekberova Z.S., Guzov I.I. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2008, 26:436-441.
41. Zorgdrager A., De Keyser J. Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci 1997, 149:95-97.
42. Zorgdrager A., De Keyser J. The premenstrual period and exacerbations in multiple sclerosis. Eur Neurol 2002, 48:204-206.
43. Tomassini V., Onesti E., Mainero C., Giugni E., Paolillo A., Salvetti M., et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 2005, 76:272-275.
44. Pozzilli C., Falaschi P., Mainero C., Martocchia A., D'Urso R., Proietti A., et al. MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology 1999, 53:622-624.
45. Bansil S., Lee H.J., Jindal S., Holtz C.R., Cook S.D. Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand 1999, 99:91-94.
46. Tengstrand B., Ahlmen M., Hafstrom I. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol 2004, 31:214-222.
47. Latman N.S. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am J Med 1983, 74:957-960.
48. Rudge S.R., Kowanko I.C., Drury P.L. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. Ann Rheum Dis 1983, 42:425-430.
49. McDonagh J.E., Singh M.M., Griffiths I.D. Menstrual arthritis. Ann Rheum Dis 1993, 52:65-66.
50. Tam A., Morrish D., Wadsworth S., Dorscheid D., Man S.F., Sin D.D. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health 2011, 11:24.
51. Fasco M.J., Hurteau G.J., Spivack S.D. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002, 188:125-140.
52. Hanley S.P. Asthma variation with menstruation. Br J Dis Chest 1981, 75:306-308.
53. Chandler M.H., Schuldheisz S., Phillips B.A., Muse K.N. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997, 17:224-234.
54. Gibbs C.J., Coutts I.I., Lock R., Finnegan O.C., White R.J. Premenstrual exacerbation of asthma. Thorax 1984, 39:833-836.
55. Eliasson O., Scherzer H.H., DeGraff A.C. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986, 77:87-94.
56. Skobeloff E.M., Spivey W.H., Silverman R., Eskin B.A., Harchelroad F., Alessi T.V. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996, 156:1837-1840.
57. Zimmerman J.L., Woodruff P.G., Clark S., Camargo C.A. Relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med 2000, 162:512-515.
58. Boggess K.A., Williamson H.O., Homm R.J. Influence of the menstrual cycle on systemic diseases. Obstet Gynecol Clin North Am 1990, 17:321-342.
59. Schoene R.B., Robertson H.T., Pierson D.J., Peterson A.P. Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women. J Appl Physiol 1981, 50:1300-1305.
60. Haggerty C.L., Ness R.B., Kelsey S., Waterer G.W. The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol 2003, 90:284-291. quiz 91-3, 347.
61. Farha S., Asosingh K., Laskowski D., Hammel J., Dweik R.A., Wiedemann H.P., et al. Effects of the menstrual cycle on lung function variables in women with asthma. Am J Respir Crit Care Med 2009, 180:304-310.
62. Pauli B.D., Reid R.L., Munt P.W., Wigle R.D., Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989, 140:358-362.
63. Hayashi T., Adachi Y., Hasegawa K., Morimoto M. Less sensitivity for late airway inflammation in males than females in BALB/c mice. Scand J Immunol 2003, 57:562-567.
64. Ligeiro de Oliveira A.P., Oliveira-Filho R.M., da Silva Z.L., Borelli P., Tavares de Lima W. Regulation of allergic lung inflammation in rats: interaction between estradiol and corticosterone. Neuroimmunomodulation 2004, 11:20-27.
65. Shames R.S., Heilbron D.C., Janson S.L., Kishiyama J.L., Au D.S., Adelman D.C. Clinical differences among women with and without self-reported perimenstrual asthma. Ann Allergy Asthma Immunol 1998, 81:65-72.
66. Letterie G.S., Fredlund P.N. Catamenial insulin reactions treated with a long-acting gonadotropin releasing hormone agonist. Arch Intern Med 1994, 154:1868-1870.
67. Ovalle F., Vaughan T.B., Sohn J.E., Gower B. Catamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literature. Am J Med Sci 2008, 335:298-303.
68. Walsh C.H., Malins J.M. Menstruation and control of diabetes. Br Med J 1977, 2:177-179.
69. Goldner W.S., Kraus V.L., Sivitz W.I., Hunter S.K., Dillon J.S. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther 2004, 6:473-480.
70. Kanaya A.M., Herrington D., Vittinghoff E., Lin F., Grady D., Bittner V., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003, 138:1-9.
71. Jarrett R.J., Graver H.J. Changes in oral glucose tolerance during the menstrual cycle. Br Med J 1968, 2:528-529.
72. Brennan I.M., Feltrin K.L., Nair N.S., Hausken T., Little T.J., Gentilcore D., et al. Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. Am J Physiol Gastrointest Liver Physiol 2009, 297:G602-G610.
73. Wald A., Van Thiel D.H., Hoechstetter L., Gavaler J.S., Egler K.M., Verm R., et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981, 80:1497-1500.
74. Cawood E.H., Bancroft J., Steel J.M. Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control. Diabet Med 1993, 10:444-448.
75. Trout K.K., Teff K.L. Insulin sensitivity and premenstrual syndrome. Curr Diab Rep 2004, 4:273-280.
76. Blum C.A., Muller B., Huber P., Kraenzlin M., Schindler C., De Geyter C., et al. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 2005, 90:3230-3235.
77. Geer E.B., Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009, 6(Suppl 1):60-75.
78. Tiittanen M., Huupponen J.T., Knip M., Vaarala O. Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro. Diabetes 2006, 55:3446-3454.
79. Strotmeyer E.S., Steenkiste A.R., Foley T.P., Berga S.L., Dorman J.S. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003, 26:1016-1021.
80. Gaborit N., Varro A., Le Bouter S., Szuts V., Escande D., Nattel S., et al. Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J Mol Cell Cardiol 2010, 49:639-646.
81. Kuch B., Hense H.W., Sinnreich R., Kark J.D., von Eckardstein A., Sapoznikov D., et al. Determinants of short-period heart rate variability in the general population. Cardiology 2001, 95:131-138.
82. Stramba-Badiale M., Spagnolo D., Bosi G., Schwartz P.J. Are gender differences in QTc present at birth? MISNES Investigators. Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome. Am J Cardiol 1995, 75:1277-1278.
83. Stramba-Badiale M., Locati E.H., Martinelli A., Courville J., Schwartz P.J. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 1997, 18:1000-1006.
84. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993, 270:2590-2597.
85. Burke J.H., Ehlert F.A., Kruse J.T., Parker M.A., Goldberger J.J., Kadish A.H. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997, 79:178-181.
86. Rodriguez I., Kilborn M.J., Liu X.K., Pezzullo J.C., Woosley R.L. Drug-induced QT prolongation in women during the menstrual cycle. JAMA 2001, 285:1322-1326.
87. Nakagawa M., Ooie T., Takahashi N., Taniguchi Y., Anan F., Yonemochi H., et al. Influence of menstrual cycle on QT interval dynamics. Pacing Clin Electrophysiol 2006, 29:607-613.
88. Jonsson M.K., Vos M.A., Duker G., Demolombe S., van Veen T.A. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology. Pharmacol Ther 2010, 127:9-18.
89. Goldstein J.M., Link B.G. Gender and the expression of schizophrenia. J Psychiatr Res 1988, 22:141-155.
90. Glick I.D., Stewart D. A new drug treatment for premenstrual exacerbation of schizophrenia. Compr Psychiatry 1980, 21:281-287.
91. Huber T.J., Borsutzky M., Schneider U., Emrich H.M. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004, 109:269-274.
92. Riecher-Rossler A., Hafner H., Stumbaum M., Maurer K., Schmidt R. Can estradiol modulate schizophrenic symptomatology?. Schizophr Bull 1994, 20:203-214.
93. Gattaz W.F., Vogel P., Riecher-Rossler A., Soddu G. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 1994, 36:137-139.
94. Hafner H., Behrens S., De Vry J., Gattaz W.F. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci 1991, 241:65-68.
95. Di Paolo T., Poyet P., Labrie F. Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sci 1982, 31:2921-2929.
96. Disshon K.A., Boja J.W., Dluzen D.E. Inhibition of striatal dopamine transporter activity by 17beta-estradiol. Eur J Pharmacol 1998, 345:207-211.
97. Hruska R.E. Elevation of striatal dopamine receptors by estrogen: dose and time studies. J Neurochem 1986, 47:1908-1915.